Literature DB >> 19966279

Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein.

Dirk Roymans1, Hendrik L De Bondt, Eric Arnoult, Peggy Geluykens, Tom Gevers, Marcia Van Ginderen, Nick Verheyen, Hidong Kim, Rudy Willebrords, Jean-François Bonfanti, Wouter Bruinzeel, Maxwell D Cummings, Herman van Vlijmen, Koen Andries.   

Abstract

Six-helix bundle (6HB) formation is an essential step for many viruses that rely on a class I fusion protein to enter a target cell and initiate replication. Because the binding modes of small molecule inhibitors of 6HB formation are largely unknown, precisely how they disrupt 6HB formation remains unclear, and structure-based design of improved inhibitors is thus seriously hampered. Here we present the high resolution crystal structure of TMC353121, a potent inhibitor of respiratory syncytial virus (RSV), bound at a hydrophobic pocket of the 6HB formed by amino acid residues from both HR1 and HR2 heptad-repeats. Binding of TMC353121 stabilizes the interaction of HR1 and HR2 in an alternate conformation of the 6HB, in which direct binding interactions are formed between TMC353121 and both HR1 and HR2. Rather than completely preventing 6HB formation, our data indicate that TMC353121 inhibits fusion by causing a local disturbance of the natural 6HB conformation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19966279      PMCID: PMC2806771          DOI: 10.1073/pnas.0910108106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein.

Authors:  Hsien-Sheng Yin; Reay G Paterson; Xiaolin Wen; Robert A Lamb; Theodore S Jardetzky
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-17       Impact factor: 11.205

2.  Two domains that control prefusion stability and transport competence of the measles virus fusion protein.

Authors:  Joshua Doyle; Andrew Prussia; Laura K White; Aiming Sun; Dennis C Liotta; James P Snyder; Richard W Compans; Richard K Plemper
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41.

Authors:  Shuwen Liu; Hong Lu; Qian Zhao; Yuxian He; Jinkui Niu; Asim K Debnath; Shuguang Wu; Shibo Jiang
Journal:  Biochim Biophys Acta       Date:  2005-03-24

4.  Design of a small-molecule entry inhibitor with activity against primary measles virus strains.

Authors:  Richard K Plemper; Joshua Doyle; Aiming Sun; Andrew Prussia; Li-Ting Cheng; Paul A Rota; Dennis C Liotta; James P Snyder; Richard W Compans
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

5.  Small molecules VP-14637 and JNJ-2408068 inhibit respiratory syncytial virus fusion by similar mechanisms.

Authors:  Janet L Douglas; Marites L Panis; Edmund Ho; Kuei-Ying Lin; Steve H Krawczyk; Deborah M Grant; Ruby Cai; Swami Swaminathan; Xiaowu Chen; Tomas Cihlar
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

6.  Rationally designed anti-HIV peptides containing multifunctional domains as molecule probes for studying the mechanisms of action of the first and second generation HIV fusion inhibitors.

Authors:  Zhi Qi; Weiguo Shi; Na Xue; Chungen Pan; Weiguo Jing; Keliang Liu; Shibo Jiang
Journal:  J Biol Chem       Date:  2008-07-28       Impact factor: 5.157

7.  Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion.

Authors:  Rupert J Russell; Philip S Kerry; David J Stevens; David A Steinhauer; Stephen R Martin; Steven J Gamblin; John J Skehel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-12       Impact factor: 11.205

8.  Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein.

Authors:  Katharine N Bossart; Bruce A Mungall; Gary Crameri; Lin-Fa Wang; Bryan T Eaton; Christopher C Broder
Journal:  Virol J       Date:  2005-07-18       Impact factor: 4.099

9.  Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation.

Authors:  Hsien-Sheng Yin; Xiaolin Wen; Reay G Paterson; Robert A Lamb; Theodore S Jardetzky
Journal:  Nature       Date:  2006-01-05       Impact factor: 49.962

Review 10.  Virus membrane-fusion proteins: more than one way to make a hairpin.

Authors:  Margaret Kielian; Félix A Rey
Journal:  Nat Rev Microbiol       Date:  2006-01       Impact factor: 60.633

View more
  37 in total

1.  Inhibitory Effect of PIK-24 on Respiratory Syncytial Virus Entry by Blocking Phosphatidylinositol-3 Kinase Signaling.

Authors:  Li-Feng Chen; Wei-Bin Xu; Yue-Yue Li; Neng-Hua Chen; Ding Luo; Qiao-Yun Song; Wei Tang; Zhi-Gang Huang; Yao-Lan Li; Zhong Liu; Man-Mei Li
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

2.  A fluorescence polarization assay using an engineered human respiratory syncytial virus F protein as a direct screening platform.

Authors:  Minyoung Park; Hisae Matsuura; Robert A Lamb; Annelise E Barron; Theodore S Jardetzky
Journal:  Anal Biochem       Date:  2010-11-05       Impact factor: 3.365

3.  Identification of a gp41 core-binding molecule with homologous sequence of human TNNI3K-like protein as a novel human immunodeficiency virus type 1 entry inhibitor.

Authors:  Yun Zhu; Lu Lu; Liling Xu; Hengwen Yang; Shibo Jiang; Ying-Hua Chen
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

4.  Efficient replication of a paramyxovirus independent of full zippering of the fusion protein six-helix bundle domain.

Authors:  Melinda A Brindley; Philippe Plattet; Richard Karl Plemper
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

5.  Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes.

Authors:  Jason S McLellan; Yongping Yang; Barney S Graham; Peter D Kwong
Journal:  J Virol       Date:  2011-05-25       Impact factor: 5.103

Review 6.  Cell entry of enveloped viruses.

Authors:  Richard K Plemper
Journal:  Curr Opin Virol       Date:  2011-08       Impact factor: 7.090

7.  Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors.

Authors:  Dan Yan; Sujin Lee; Vidhi D Thakkar; Ming Luo; Martin L Moore; Richard Karl Plemper
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

8.  GS-5806 inhibits pre- to postfusion conformational changes of the respiratory syncytial virus fusion protein.

Authors:  Dharmaraj Samuel; Weimei Xing; Anita Niedziela-Majka; Jinny S Wong; Magdeleine Hung; Katherine M Brendza; Michel Perron; Robert Jordan; David Sperandio; Xiaohong Liu; Richard Mackman; Roman Sakowicz
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191

Review 9.  Structure and function of respiratory syncytial virus surface glycoproteins.

Authors:  Jason S McLellan; William C Ray; Mark E Peeples
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

10.  Mucosal delivery of a double-stapled RSV peptide prevents nasopulmonary infection.

Authors:  Gregory H Bird; Sandhya Boyapalle; Terianne Wong; Kwadwo Opoku-Nsiah; Raminder Bedi; W Christian Crannell; Alisa F Perry; Huy Nguyen; Viviana Sampayo; Ankita Devareddy; Subhra Mohapatra; Shyam S Mohapatra; Loren D Walensky
Journal:  J Clin Invest       Date:  2014-04-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.